Calyxt Reports First Quarter 2023 Financial Results and Prov

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its first quarter...

Related Keywords

Roseville , California , United States , San Diego , Minnesota , Michaela Carr , Rory Riggs , Sw Seed Company , Calyxt Inc , Cibus Global , Current Customer Projects Under Development , Cibus Inc , Exchange Commission , Prnewswire Calyxt Inc , Nasdaq , Cibus Global Expected , Evologic Technologies , Plant Cell Matrix , Merger Agreement , Special Meeting , Chief Executive Officer , Nasdaq Capital Market , Chief Executive , Registration Statement , Nasdaq Capital , Customer Projects Under Development , Global Infrastructure Partner , Completed Initial Phase , Projectto Scale Calyxt , Proprietary Plant Cell Matrix , Evologic Technologies Gmbh , Three Months Ended March , Securities Litigation Reform Act , Annual Report , Ridge Road , Thousands Except Par Value , Share Amounts , Thousands Except Shares , Per Share Amounts , Calyxt , Nc , Computer Amp Electronics , Biotechnology , Medical Pharmaceuticals , Health Care Amp Hospitals , Earnings ,